Synthesis and in Vitro Pharmacology of Substituted Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate Transport

Por um escritor misterioso
Last updated 10 novembro 2024
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Inhibition of the Vesicular Glutamate Transporter (VGLUT) with Congo Red Analogs: New Binding Insights
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs - ScienceDirect
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype-2 and -3 (mGlu2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
VGLUT substrates and inhibitors: A computational viewpoint - ScienceDirect
Dimethyl 2-Ketoglutaconate (CAS 13192-04-6)
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Dimethyl 2-Ketoglutaconate | CAS 13192-04-6
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
3-Acetyl-11-keto-β-boswellic Acid-Based Hybrids Alleviate Acetaminophen-Induced Hepatotoxicity in HepG2 by the Regulation of Inflammatory and Oxidative Stress Pathways: An Integrated Approach
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Frontiers Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy?
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Design, synthesis and biological evaluation of small-azo-dyes as potent Vesicular Glutamate Transporters inhibitors - ScienceDirect
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
VGLUT substrates and inhibitors: A computational viewpoint - ScienceDirect
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Synthesis, in vitro inhibitor screening, structure–activity relationship, and molecular dynamic simulation studies of novel thioquinoline derivatives as potent α-glucosidase inhibitors
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Modulation of Hippocampal Synaptic Transmission by the Kynurenine Pathway Member Xanthurenic Acid and Other VGLUT Inhibitors
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Christina N Carrigan's research works University of Montana, Missoula (UMT) and other places
Synthesis and in Vitro Pharmacology of Substituted  Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate  Transport
Development of a Robust Synthesis of Dactolisib on a Commercial Manufacturing Scale

© 2014-2024 immanuelipc.com. All rights reserved.